Evidence map›Paper›PMID 24942568›Full record

ArticleJournal of virology2014

Immune activation is associated with CD8 T cell interleukin-21 production in HIV-1-infected individuals.

LaTonya D Williams, Nilesh Amatya, Anju Bansal, Steffanie Sabbaj, Sonya L Heath, Irini Sereti, Paul A Goepfert

Open access · bronzeAbstract read
In one paragraph

Article in Journal of virology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.8field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 11 citations in OpenAlex.

  1. T-Follicular-Like CD8Frontiers in immunology · 2022
    Article
  2. HIV co-infection augments EBV-induced tumorigenesisFrontiers in virology (Lausanne, Switzerland) · 2022
    Article
  3. Interleukin-21 in Viral Infections.International journal of molecular sciences · 2021
    Review
  4. IL-21 Expands HIV-1-Specific CD8Journal of immunology research · 2019
    Article
  5. Article
  6. IL-21 Signaling in Immunity.F1000Research · 2016
    Review
  7. Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

LaTonya D WilliamsDepartment of Microbiology, University of Alabama at Birmingham, Birmingham, Alabama, USA.
Nilesh AmatyaDepartment of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, USA.
Anju BansalDepartment of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, USA.
Steffanie SabbajDepartment of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, USA.
Sonya L HeathDepartment of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, USA.
Irini SeretiLaboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.
Paul A GoepfertDepartment of Microbiology, University of Alabama at Birmingham, Birmingham, Alabama, USA Department of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, USA paulg@uab.edu.
University of Alabama at Birmingham · USNational Institute of Allergy and Infectious Diseases · US

Funding

Virology CoreP30AI027767 · NIAID · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI Paul A. Goepfert · 1988 to 2026
$84.1M
Immunopathogenic Mechanisms of Human Immunodeficiency Virus (HIV) DiseaseZIAAI001121 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI SERETI, IRINI · 2010 to 2025
$27.2M
IMMUNOLOGIC DISEASES AND BASIC IMMUNOLOGYT32AI007051 · NIAID · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI Laurie Ellen Harrington · 1985 to 2026
$13.1M
Ruth L. Kirschstein National Research Service Award (NRSA)- T32T32AI007392 · NIAID · DUKE UNIVERSITY · PI Amy Lynn Corneli, Guido Ferrari · 1990 to 2026
$9.8M
HIV-1 Cryptic Epitopes: Implications for Vaccine DesignR01AI084772 · NIAID · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI GOEPFERT, PAUL A. · 2009 to 2013
$2.5M
IL- 21 and Immune Mediated Viral ControlU01AI082966 · NIAID · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI ZAJAC, ALLAN J · 2009 to 2013
$2.3M
Interleukin-21 Immune Mediated Control of HIV-1F31AI085970 · NIAID · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI WILLIAMS, LATONYA DENISE · 2010 to 2011
$61k
Intramural NIH HHSNIAID NIH HHS AI084772NIAID NIH HHS F31 AI085970NIAID NIH HHS P30 AI027767NIAID NIH HHS P30 AI64510NIAID NIH HHS R01 AI082966NIAID NIH HHS R01 AI084772NIAID NIH HHS T32 AI007051NIAID NIH HHS T32 AI007392NIAID NIH HHS U01 AI082966
6 · The paper itself

Abstract

Interleukin-21 (IL-21) can be produced by CD8 T cells from HIV-1-infected individuals and those with autoimmune disease, but the mechanism remains poorly understood. Here we demonstrate that IL-21-producing CD8 T cells are not associated with CD4 depletion and are absent in patients with idiopathic CD4 lymphocytopenia. Instead, IL-21 production by CD8 T cells was associated with high levels of activation, suggesting that these cells emerge as a consequence of excessive chronic immune activation rather than CD4 lymphopenia.

Indexed as

CD4-Positive T-LymphocytesCD8-Positive T-LymphocytesHIV-1HIV InfectionsHumansInterleukin-21InterleukinsLymphocyte ActivationInterleukin-21Interleukins

Identifiers

PMID24942568
PMCPMC4136345
OpenAlexW2039005626

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.